Wells Fargo’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.4K Sell
43,172
-9,758
-18% -$5.28K ﹤0.01% 5315
2025
Q1
$34.7K Buy
52,930
+2,514
+5% +$1.65K ﹤0.01% 5059
2024
Q4
$51.4K Sell
50,416
-9,650
-16% -$9.84K ﹤0.01% 4982
2024
Q3
$52K Sell
60,066
-4,907
-8% -$4.25K ﹤0.01% 4929
2024
Q2
$23.3K Sell
64,973
-69,384
-52% -$24.9K ﹤0.01% 5168
2024
Q1
$90K Sell
134,357
-36,548
-21% -$24.5K ﹤0.01% 4577
2023
Q4
$92.9K Sell
170,905
-153,766
-47% -$83.5K ﹤0.01% 4545
2023
Q3
$195K Sell
324,671
-22,402
-6% -$13.4K ﹤0.01% 4060
2023
Q2
$451K Sell
347,073
-167,305
-33% -$217K ﹤0.01% 3812
2023
Q1
$905K Buy
514,378
+113,905
+28% +$200K ﹤0.01% 3228
2022
Q4
$1.26M Sell
400,473
-45,526
-10% -$143K ﹤0.01% 2927
2022
Q3
$2.19M Sell
445,999
-29,482
-6% -$144K ﹤0.01% 2513
2022
Q2
$1.97M Sell
475,481
-108,601
-19% -$450K ﹤0.01% 2660
2022
Q1
$3.39M Sell
584,082
-20,622
-3% -$120K ﹤0.01% 2644
2021
Q4
$4.54M Sell
604,704
-52,110
-8% -$391K ﹤0.01% 2518
2021
Q3
$5.92M Sell
656,814
-33,383
-5% -$301K ﹤0.01% 2566
2021
Q2
$8.26M Buy
690,197
+31,242
+5% +$374K ﹤0.01% 2299
2021
Q1
$8.26M Sell
658,955
-132,125
-17% -$1.66M ﹤0.01% 2263
2020
Q4
$12.3M Sell
791,080
-57,940
-7% -$904K ﹤0.01% 1910
2020
Q3
$8.02M Buy
849,020
+34,629
+4% +$327K ﹤0.01% 2050
2020
Q2
$7.3M Buy
814,391
+145,254
+22% +$1.3M ﹤0.01% 2100
2020
Q1
$4.26M Buy
669,137
+27,168
+4% +$173K ﹤0.01% 2331
2019
Q4
$5.37M Sell
641,969
-196,161
-23% -$1.64M ﹤0.01% 2482
2019
Q3
$7.59M Buy
838,130
+16,710
+2% +$151K ﹤0.01% 2157
2019
Q2
$8.85M Buy
821,420
+164,784
+25% +$1.77M ﹤0.01% 2053
2019
Q1
$6.27M Buy
656,636
+231
+0% +$2.2K ﹤0.01% 2328
2018
Q4
$7.54M Sell
656,405
-233,829
-26% -$2.68M ﹤0.01% 2059
2018
Q3
$15.1M Buy
890,234
+100,253
+13% +$1.7M ﹤0.01% 1732
2018
Q2
$11.2M Buy
789,981
+234,346
+42% +$3.33M ﹤0.01% 1968
2018
Q1
$10.6M Sell
555,635
-37,927
-6% -$721K ﹤0.01% 1954
2017
Q4
$9.74M Buy
593,562
+118,794
+25% +$1.95M ﹤0.01% 2015
2017
Q3
$7.12M Buy
474,768
+43,534
+10% +$653K ﹤0.01% 2230
2017
Q2
$3.8M Buy
431,234
+135,464
+46% +$1.19M ﹤0.01% 2631
2017
Q1
$1.54M Buy
295,770
+34,128
+13% +$177K ﹤0.01% 3377
2016
Q4
$798K Sell
261,642
-30,994
-11% -$94.5K ﹤0.01% 3783
2016
Q3
$1.35M Buy
292,636
+24,161
+9% +$112K ﹤0.01% 3214
2016
Q2
$1.56M Buy
268,475
+5,360
+2% +$31K ﹤0.01% 3116
2016
Q1
$1.59M Buy
263,115
+49,529
+23% +$300K ﹤0.01% 3050
2015
Q4
$1.95M Buy
213,586
+44,875
+27% +$410K ﹤0.01% 2952
2015
Q3
$952K Buy
168,711
+14,375
+9% +$81.1K ﹤0.01% 3458
2015
Q2
$1.71M Buy
154,336
+46,975
+44% +$521K ﹤0.01% 3160
2015
Q1
$1.68M Buy
107,361
+10,702
+11% +$168K ﹤0.01% 3120
2014
Q4
$1.47M Buy
96,659
+4,470
+5% +$68K ﹤0.01% 3196
2014
Q3
$994K Buy
92,189
+19,833
+27% +$214K ﹤0.01% 3444
2014
Q2
$1.11M Buy
72,356
+27,661
+62% +$422K ﹤0.01% 3412
2014
Q1
$809K Sell
44,695
-75,041
-63% -$1.36M ﹤0.01% 3587
2013
Q4
$1.66M Buy
119,736
+37,441
+45% +$520K ﹤0.01% 3051
2013
Q3
$863K Buy
82,295
+7,300
+10% +$76.6K ﹤0.01% 3424
2013
Q2
$586K Buy
+74,995
New +$586K ﹤0.01% 3577